Dynavax Technologies Corp (NASDAQ:DVAX)
| 16.08 Delayed Data As of Nov 29 |  -0.25 / -1.53%Today’s Change | 4.36 Today|||52-Week Range 21.39 | +261.35% Year-to-Date |
Latest DVAX News | Press Releases
No recent news for Dynavax Technologies Corp.
Today’s Trading
| Previous close | 16.32 |
| Today’s open | 16.78 |
| Day’s range | 16.02 - 17.11 |
| Volume | 2,955,461 |
| Average volume (3 months) | 4,140,948 |
| Market cap | $2.0B |
Data as of 4:00pm ET, 11/29/2021
Growth & Valuation
| Earnings growth (last year) | +65.49% |
| Earnings growth (this year) | +152.24% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +32.18% |
| P/E ratio | NM |
| Price/Sales | 9.63 |
| Price/Book | 30.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NSTGNanoString Technolog... | -0.73 | -1.75% |
| CDMOAvid Bioservices Inc | -1.03 | -3.27% |
| NKTRNektar Therapeutics | -0.10 | -0.89% |
| SRNESorrento Therapeutic... | -0.05 | -0.84% |
Data as of 4:00pm ET, 11/29/2021
Financials
| Next reporting date | March 9, 2022 |
| EPS forecast (this quarter) | $0.60 |
| Annual revenue (last year) | $46.6M |
| Annual profit (last year) | -$75.2M |
| Net profit margin | -161.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
